Epidermal growth factor receptor and rectal cancer:: In regard to Kim et al. (Int J Radiat Oncol Biol Phys 2006;66:195-200)

被引：0
作者：
Bibeau, Frederic [1 ]
Sennesse, Pierre
Boissiere, Florence
Azria, David
机构：
[1] Univ Montpellier, Dept Pathol, Ctr Rech Cancerol Montpellier, Montpellier, France
[2] Univ Montpellier, Dept Digest Oncol, Ctr Rech Cancerol Montpellier, Montpellier, France
[3] Univ Montpellier, Dept Radiat Oncol, Ctr Rech Cancerol Montpellier, Montpellier, France
[4] Ctr Reg Lutte Canc Val dAurelle Paul Lamarque, Montpellier, France
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2007年 / 67卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2006.09.028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：318 / 318
页数：1
相关论文
共 9 条
[1]   Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer -: art. no. 62 [J].
Azria, D ;
Bibeau, F ;
Barbier, N ;
Zouhair, A ;
Lemanski, C ;
Rouanet, P ;
Ychou, M ;
Ozsahin, M ;
Pèlegrin, AP ;
Dubois, JB ;
Thèzenas, ST .
BMC CANCER, 2005, 5 (1)
[2]   Rectal cancer: Local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging - A meta-analysis [J].
Bipat, S ;
Glas, AS ;
Slors, FJM ;
Zwinderman, AH ;
Bossuyt, PMM ;
Stoker, J .
RADIOLOGY, 2004, 232 (03) :773-783
[3]   Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry [J].
Chung, KY ;
Shia, J ;
Kemeny, NE ;
Shah, M ;
Schwartz, GK ;
Tse, A ;
Hamilton, A ;
Pan, D ;
Schrag, D ;
Schwartz, L ;
Klimstra, DS ;
Fridman, D ;
Kelsen, DP ;
Saltz, LB .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) :1803-1810
[4]   Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer [J].
Cunningham, D ;
Humblet, Y ;
Siena, S ;
Khayat, D ;
Bleiberg, H ;
Santoro, A ;
Bets, D ;
Mueser, M ;
Harstrick, A ;
Verslype, C ;
Chau, I ;
Van Cutsem, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (04) :337-345
[5]   The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy:: a multicenter, retrospective analysis [J].
Giralt, J ;
de las Heras, M ;
Cerezo, L ;
Eraso, A ;
Hermosilla, E ;
Velez, D ;
Lujan, J ;
Espin, E ;
Rossello, J ;
Majó, J ;
Benavente, S ;
Armengol, M ;
de Torres, I .
RADIOTHERAPY AND ONCOLOGY, 2005, 74 (02) :101-108
[6]   Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapy [J].
Giralt, J ;
Eraso, A ;
Armengol, M ;
Rosselló, J ;
Majó, J ;
Ares, C ;
Espin, E ;
Benavente, S ;
de Torres, I .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (05) :1460-1465
[7]   Epidermal growth factor receptor as a predictor of tumor downstaging in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy [J].
Kim, Jun-Sang ;
Kim, Jin-Man ;
Li, Shengjin ;
Yoon, Wan-Hee ;
Song, Kyu-Sang ;
Kim, Ki-Hwan ;
Yeo, Seung-Gu ;
Nam, Ji Sook ;
Cho, Moon-June .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (01) :195-200
[8]   KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer [J].
Lièvre, A ;
Bachet, JB ;
Le Corre, D ;
Boige, V ;
Landi, B ;
Emile, JF ;
Côté, JF ;
Tomasic, G ;
Penna, C ;
Ducreux, M ;
Rougier, P ;
Penault-Llorca, F ;
Laurent-Puig, P .
CANCER RESEARCH, 2006, 66 (08) :3992-3995
[9]   Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study [J].
Moroni, M ;
Veronese, S ;
Benvenuti, S ;
Marrapese, G ;
Sartore-Bianchi, A ;
Di Nicolantonio, F ;
Gambacorta, M ;
Siena, S ;
Bardelli, A .
LANCET ONCOLOGY, 2005, 6 (05) :279-286
1